BioCentury
ARTICLE | Company News

Cellectis, Iowa State University deal

November 5, 2012 8:00 AM UTC

Cellectis received two exclusive licenses from the university covering technologies related to transcription activator-like effector nucleases (TALENs) and monomeric TALE nucleases. Cellectis said TAL...